{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:08:43Z","timestamp":1790485723203,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Patients with left-sided breast cancer have an increased risk of cardiovascular disease (CVD) after radiotherapy (RT). While the awareness of cardiac toxicity has increased enormously over the last decade, the role of individual baseline cardiac risks has not yet been systematically investigated. Aim of the present study was to evaluate the impact of baseline CVD risks on radiation-induced cardiac toxicity.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Two hundred ten patients with left-sided breast cancer treated in the prospective Save-Heart Study using a deep inspiration breath-hold (DIBH) technique were analysed regarding baseline risk factors for CVD. Three frequently used prediction tools (Procam, Framingham and Reynolds score) were applied to evaluate the individual CVD risk profiles. Moreover, 10-year CVD excess absolute risks (EAR) were estimated using the individual mean heart dose (MHD) of treatment plans in free breathing (FB) and DIBH.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The individual baseline CVD risk factors had a strong impact on the 10-year cumulative CVD risk. The mean baseline risks of the non-diabetic cohort (<jats:italic>n<\/jats:italic>\u2009=\u2009200) ranged from 3.11 to 3.58%, depending on the risk estimation tool. A large number of the non-diabetic patients had a very low 10-year CVD baseline risk of \u22641%; nevertheless, 8\u20139% of patients reached \u226510% baseline 10-year CVD risk. In contrast, diabetic patients (<jats:italic>n<\/jats:italic>\u2009=\u200910) had significantly higher baseline CVD risks (range: 11.76\u201324.23%). The mean 10-year cumulative risk (Framingham score) following RT was 3.73% using the DIBH-technique (MHD:1.42Gy) and 3.94% in FB (MHD:2.33Gy), after adding a 10-year-EAR of +\u20090.34%(DIBH) and\u2009+\u20090.55%(FB) to the baseline risks, respectively. Smoking status was one of the most important and modifiable baseline risk factors. After DIBH-RT, the 182 non-smoking patients had a mean 10-year cumulative risk of 3.55% (3.20% baseline risk, 0.35% EAR) as compared to 6.07% (5.60% baseline risk, 0.47% EAR) for the 28 smokers.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>In the present study, all CVD prediction tools showed comparable results and could easily be integrated into daily clinical practice. A systematic evaluation and screening helps to identify high-risk patients who may benefit from primary prevention. This could result in an even higher benefit than from heart-sparing irradiation techniques alone.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13014-020-01520-8","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T08:02:32Z","timestamp":1590307352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks"],"prefix":"10.1186","volume":"15","author":[{"given":"Aur\u00e9lie","family":"Gaasch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Sch\u00f6necker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristoforo","family":"Simonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Eidem\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Pazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Reitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Rottler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Freislederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"W\u00fcrstlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Harbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Niyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Belka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,24]]},"reference":[{"key":"1520_CR1","first-page":"253","volume":"41","author":"M Gulati","year":"2018","unstructured":"Gulati M. Mulvagh S. The connection between the breast and heart in a woman: Breast cancer and cardiovascular disease Clin Cardiol. 2018;41:253\u20137.","journal-title":"The connection between the breast and heart in a woman: Breast cancer and cardiovascular disease Clin Cardiol"},{"key":"1520_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987\u201398.","journal-title":"N Engl J Med"},{"issue":"5","key":"1520_CR3","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.ijrobp.2007.05.034","volume":"69","author":"CW Taylor","year":"2007","unstructured":"Taylor CW, Nisbet A, McGale P, et al. Cardiac exposures in breast cancer radiotherapy: 1950s\u20131990s. Int J Radiat Oncol Biol Phys. 2007;69(5):1484\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1520_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijrobp.2007.12.058","volume":"72","author":"CW Taylor","year":"2008","unstructured":"Taylor CW, Povall JM, McGale P, Nisbet A, Dodwell D, Smith JT, et al. Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys. 2008;72:501\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1520_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00066-017-1213-y","volume":"194","author":"S Corradini","year":"2018","unstructured":"Corradini S, Ballhausen H, Weingandt H, Freislederer P, Sch\u00f6necker S, Niyazi M, Simonetto C, Eidem\u00fcller M, Ganswindt U, Belka C. Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease. Strahlenther Onkol. 2018;194(3):196\u2013205.","journal-title":"Strahlenther Onkol"},{"key":"1520_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.radonc.2012.02.008","volume":"103","author":"A Sardaro","year":"2012","unstructured":"Sardaro A, Petruzzelli MF, D'Errico MP, Grimaldi L, Pili G, Portaluri M. Radiation-induced cardiac damage in early left breast cancer patients: risk factors, biological mechanisms, radiobiology, and dosimetric constraints. Radiother Oncol. 2012;103:133\u201342.","journal-title":"Radiother Oncol"},{"key":"1520_CR7","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837\u201347.","journal-title":"Circulation"},{"key":"1520_CR8","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","volume":"100","author":"SM Grundy","year":"1999","unstructured":"Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134\u201346.","journal-title":"Circulation"},{"key":"1520_CR9","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1200\/JCO.2005.05.1037","volume":"24","author":"EE Harris","year":"2006","unstructured":"Harris EE, Correa C, Hwang WT, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol. 2006;24:4100\u20136.","journal-title":"J Clin Oncol"},{"key":"1520_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-018-4723-0","volume":"170","author":"SAM Gernaat","year":"2018","unstructured":"Gernaat SAM, Boer JMA, van den Bongard DHJ, Maas AHEM, van der Pol CC, Bijlsma RM, Grobbee DE, Verkooijen HM, Peeters PH. The risk of cardiovascular disease following breast cancer by Framingham risk score. Breast Cancer Res Treat. 2018;170:119\u201327.","journal-title":"Breast Cancer Res Treat"},{"key":"1520_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/djk064","volume":"99","author":"MJ Hooning","year":"2007","unstructured":"Hooning MJ, Botma A, Aleman BM, et al. Long term risk of cardiovascular disease in 10-years survivors of breast cancer. J Natl Cancer Inst. 2007;99:365\u201375.","journal-title":"J Natl Cancer Inst"},{"key":"1520_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.radonc.2018.07.024","volume":"131","author":"C Simonetto","year":"2019","unstructured":"Simonetto C, Eidem\u00fcller M, Gaasch A, Pazos M, et al. Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy. Radiother Oncol. 2019;131:202\u20137.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1520_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13014-016-0716-5","volume":"11","author":"S Sch\u00f6necker","year":"2016","unstructured":"Sch\u00f6necker S, Walter F, Freislederer P, Marisch C, Scheithauer H, Harbeck N, Corradini S, Belka C. Treatment planning and evaluationof gated radiotherapy in left-sided breast cancer patients using the catalyst\u2122\/sentinel\u2122 system for deep inspiration breath-hold (DIBH). Radiat Oncol. 2016;11(1):143.","journal-title":"Radiat Oncol"},{"issue":"10","key":"1520_CR14","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00125-009-1454-0","volume":"52","author":"P Chamnan","year":"2009","unstructured":"Chamnan P, Simmons RK, Sharp SJ, Griffin SJ, Wareham NJ. Cardiovascular risk assessment scores for people with diabetes: a systematic review. Diabetologia. 2009;52(10):2001\u201314.","journal-title":"Diabetologia"},{"issue":"12","key":"1520_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1365-2362.2007.01888.x","volume":"37","author":"H Schulte","year":"2007","unstructured":"Schulte H, Cullen P, Seedorf U. Assessing risk of myocardial infarction and stroke: new data from the prospective cardiovascular M\u00fcnster (PROCAM) study. Eur J Clin Investig. 2007;37(12):925\u201332.","journal-title":"Eur J Clin Investig"},{"issue":"9921","key":"1520_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","volume":"383","author":"SS Mahmood","year":"2014","unstructured":"Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham heart study and the epidemiology of cardiovascular diseases: a historical perspective. Lancet. 2014;383(9921):999\u20131008.","journal-title":"Lancet"},{"issue":"6","key":"1520_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jama.297.6.611","volume":"297","author":"PM Ridker","year":"2007","unstructured":"Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA. 2007;297(6):611\u20139.","journal-title":"JAMA"},{"key":"1520_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/bjc.2012.575","volume":"108","author":"KE Henson","year":"2013","unstructured":"Henson KE, McGale P, Taylor C, Darby SC. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2013;108:179\u201382.","journal-title":"Br J Cancer"},{"issue":"9438","key":"1520_CR19","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937\u201352.","journal-title":"Lancet."},{"key":"1520_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/1471-2458-13-362","volume":"13","author":"P Mallaina","year":"2013","unstructured":"Mallaina P, Lionis C, Rol H, Imperiali R, Burgess A, Nixon M, Malvestiti FM. Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: Results of the Cardiovascular Risk Assessment among Smokers in Primary Care in Europe (CV-ASPIRE) Study. BMC Public Health. 2013;13:362.","journal-title":"BMC Public Health"},{"issue":"Suppl 1","key":"1520_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21037\/tlcr.2019.05.09","volume":"8","author":"WK Evans","year":"2019","unstructured":"Evans WK, Truscott R, Cameron E, Rana S, Isaranuwatchai W, Haque M, Rabeneck L. Implementing smoking cessation within cancer treatment centres and potential economic impacts. Transl Lung Cancer Res. 2019;8(Suppl 1):11\u201320.","journal-title":"Transl Lung Cancer Res"},{"key":"1520_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0021-9150(96)05958-8","volume":"127","author":"T Korhonen","year":"1996","unstructured":"Korhonen T, Savolainen MJ, Koistinen MJ, Ik\u00e4heimo M, Linnaluoto MK, Kervinen K, Kes\u00e4niemi YA. Association of lipoprotein cholesterol and triglycerides with the severity of coronary heart disease in men and women. Atherosclerosis. 1996;127:213\u201320.","journal-title":"Atherosclerosis"},{"key":"1520_CR23","doi-asserted-by":"publisher","first-page":"b1665","DOI":"10.1136\/bmj.b1665","volume":"338","author":"MR Law","year":"2009","unstructured":"Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.","journal-title":"BMJ"},{"issue":"19","key":"1520_CR24","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.2015.15629","volume":"316","author":"R Chou","year":"2016","unstructured":"Chou R, Dana T, Blazina I, Daeges M, Jeanne TL. Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US preventive services task force. JAMA. 2016;316(19):2008\u201324.","journal-title":"JAMA"},{"issue":"5","key":"1520_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s12350-011-9425-5","volume":"18","author":"MO Versteylen","year":"2011","unstructured":"Versteylen MO, Joosen IA, Shaw LJ, Narula J, Hofstra L. Comparison of Framingham, PROCAM, SCORE, and diamond Forrester to predict coronary atherosclerosis and cardiovascular events. J Nucl Cardiol. 2011;18(5):904\u201311.","journal-title":"J Nucl Cardiol"},{"issue":"14","key":"1520_CR26","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.111.075929","volume":"125","author":"NR Cook","year":"2012","unstructured":"Cook NR, Paynter NP, Eaton CB, Manson JAE, Martin LW, Robinson JG, Rossouw JE, Wassertheil-Smoller S, Ridker PM. Comparison of the Framingham and Reynolds risk scores for global cardiovascular risk prediction in the multiethnic Women\u2019s health initiative. Circulation. 2012;125(14):1748\u201356.","journal-title":"Circulation"},{"issue":"1","key":"1520_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00066-018-1378-z","volume":"195","author":"MD Piroth","year":"2019","unstructured":"Piroth MD, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Krug D, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R. Heart toxicity from breast cancer radiotherapy: current findings, assessment, and prevention. Strahlenther Onkol. 2019 Jan;195(1):1\u201312.","journal-title":"Strahlenther Onkol"},{"issue":"10","key":"1520_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00066-019-01495-w","volume":"195","author":"MN Duma","year":"2019","unstructured":"Duma MN, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Krug D, Piroth MD, Sedlmayer F, Souchon R, Sauer R. Heart-sparing radiotherapy techniques in breast cancer patients: a recommendation of the breast cancer expert panel of the German society of radiation oncology (DEGRO). Strahlenther Onkol. 2019 Oct;195(10):861\u201371.","journal-title":"Strahlenther Onkol"},{"issue":"1\u20132","key":"1520_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/rpd\/ncy219","volume":"183","author":"M Eidem\u00fcller","year":"2019","unstructured":"Eidem\u00fcller M, Simonetto C, Kundr\u00e1t P, Ulanowski A, Shemiakina E, G\u00fcthlin D, Rennau H, Remmele J, Hildebrandt G, Wolf U. Long-term health risk after breast-cancer radiotherapy: overview of PASSOS methodology and software. Radiat Prot Dosim. 2019;183(1\u20132):259\u201363.","journal-title":"Radiat Prot Dosim"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01520-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-020-01520-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01520-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T23:18:49Z","timestamp":1621811929000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-020-01520-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,24]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1520"],"URL":"https:\/\/doi.org\/10.1186\/s13014-020-01520-8","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,24]]},"assertion":[{"value":"16 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee of the University Hospital, LMU Munich (No. 355\u201316 ex 09\/2016) and registered at German Clinical Trials Register (DRKS-ID: DRKS00011213, registered 11 January 2017, ). Written informed consent was obtained for all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CB and SC received speaker honoraria and research grants from ELEKTA AB (Stockholm, Sweden). SC and PF received speaker honoraria and research grants from C-RAD (Uppsala, Sweden). The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}